Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Hay

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Journal of Medicinal Chemistry|May 18, 2001
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonistsF E Blaney, L F Raveglia, M Artico, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonistH M Sarau, D E Griswold, B Bush, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 7, 1999
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Molecular Pharmacology|August 27, 1999
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptorH M Sarau, R S Ames, J Chambers, et al.
Nature|September 28, 1999
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14R S Ames, H M Sarau, J K Chambers, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Journal of Medicinal Chemistry|May 18, 2001
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonistsF E Blaney, L F Raveglia, M Artico, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonistH M Sarau, D E Griswold, B Bush, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 7, 1999
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Molecular Pharmacology|August 27, 1999
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptorH M Sarau, R S Ames, J Chambers, et al.
Nature|September 28, 1999
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14R S Ames, H M Sarau, J K Chambers, et al.
Pageof 12